index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

Chargement de la page

Mots clés

Aged Adeno-associated virus vector Cytokines IMNM Inflammatory myopathy Myositis Idiopathic inflammatory myopathies Fabry disease Sphingosine-1-phosphate Anti‐mitochondrial antibodies Cardio-oncology Biomarker Adult Agalsidase Anti-drug antibodies Aldostérone Anti-agalsidase antibodies Antisynthetase AAV humoral immunity Systems biology DM Female Animals Amyotrophy Adverse drug reactions IBM Lysosomal storage diseases Anti-interleukin-6 Autoantibody Myopathy Aldosterone B-lymphocyte Autoantibodies Myositis and muscle disease Auto-antibodies AAV vector Anti-Mi2 Adeno-associated virus Anémie hémolytique Acid-alpha-glucosidase Inborn errors of metabolism Adolescence Humans Case reports Skeletal muscle Anti-synthetase syndrome Arthritis Auto-immunité Analyses multidimensionnelles Immune checkpoint inhibitors Biomarqueurs Deep immune profiling Antibodies Auto‐antibodies Myocarditis Immunotherapy Inflammation Dermatomyositis Acute Kidney Injury/epidemiology/etiology Interferon Autoimmunity Adeno-associated vector Dependovirus/genetics/immunology Antibody responses Prognosis Amyotrophic lateral sclerosis Middle Aged Autoimmune diseases Data integration Antiphospholipid syndrome Anticorps anti-agalsidase AAV vectors Outcome measures Biomarkers Antisynthétase Cancer Anticorps spécifique des myosites Gene therapy Pharmacology Biopsy Male COVID-19 Mass cytometry AAV antibody Multidisciplinarity Active Assisted communication devices Interstitial lung disease AAV Bioelectrical impedance analysis Muscle Antisynthetase syndrome Anti-IgE IgG Anti-MDA5 autoantibodies B cell homeostasis Inclusion body myositis Polymyositis Abnormal movement Machine learning Adjudication